ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1982

Leptin, a Hypothalamic Signaling Hormone, Is Elevated in Fibromyalgia Patients

Robert S. Katz, Rush University Medical Center, Chicago, IL

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: fibromyalgia and laboratory tests

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 7, 2017

Title: Fibromyalgia, Soft Tissue Disorders, Regional and Specific Clinical Pain Syndromes Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Leptin, a 16 kDa protein, acts on receptors in brain neurons, especially in the hypothalamus. It could affect the hypothalamic-pituitary axis and be involved in the stress response. We analyzed leptin levels in the serum of patients with fibromyalgia and rheumatoid arthritis.

Methods: Leptin levels were assessed in 27 fibromyalgia syndrome patients and six rheumatoid arthritis patients followed in a rheumatology office practice. Leptin was measured by the University of Miami Immunology Laboratory.
Results: Leptin levels varied between 1.7 and 70.7 ng/ml (mean 28.0) in FMS patients and 0.6 to 33.0 ng/ml (mean 10.1) in rheumatoid arthritis patients. The mean leptin/BMI ratio for 20 FMS pts was 1.0. The mean leptin/BMI for RA was 0.50.
Conclusion: Leptin levels appear to be elevated in fibromyalgia patients and could provide a link between chronic stress, the hypothalamic-pituitary axis, and fibromyalgia. Leptin might be a potential therapeutic target in fibromyalgia.


Disclosure: R. S. Katz, None;

To cite this abstract in AMA style:

Katz RS. Leptin, a Hypothalamic Signaling Hormone, Is Elevated in Fibromyalgia Patients [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/leptin-a-hypothalamic-signaling-hormone-is-elevated-in-fibromyalgia-patients/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/leptin-a-hypothalamic-signaling-hormone-is-elevated-in-fibromyalgia-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology